Upstate Active Clinical Trials

Study Title:

RTOG 1008 - A Randomized Phase II Study of Adjuvant Concurrent Radiation and Chemotherapy versus Radiation Alone in Resected High-Risk Malignant Salivary Gland Tumors

What is the purpose of the study?

This randomized phase II trial is studying radiation therapy with or without chemotherapy to see how well it works in treating patients with high-risk malignant salivary gland tumors that have been removed by surgery.

Upstate Institutional Review Board (IRB) Number:

242054

Study Phase:

II

Patient Age Group:

Adults

Principal Investigator:

Seung Shin Hahn, MD

ClinicalTrials.Gov ID:

NCT01220583

For more information about this trial go to ClinicalTrials.Gov

Who can I contact for more information?

Name: Dena R Martin
Phone: 315-464-5262
Email: martind@upstate.edu

Return to Previous Page || Search Again